Abstract
The deposition of cholesterol in the arterial wall by the infiltration of low-density lipoproteins (LDLs) is a key step in the development of atherosclerosis. In this Commentary, we discuss recent recommendations for clinical laboratory measurement of low-density lipoprotein cholesterol (LDL-C) and its utility both for assessing cardiovascular disease risk and as a tool in the management of patients receiving lipid-lowering therapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 20-22 |
| Number of pages | 3 |
| Journal | Clinical Pharmacology and Therapeutics |
| Volume | 96 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2014 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
Fingerprint Dive into the research topics of 'Measurement of low-density lipoprotein cholesterol in assessment and management of cardiovascular disease risk'. Together they form a unique fingerprint.
Cite this
Jialal, I., & Remaley, A. T. (2014). Measurement of low-density lipoprotein cholesterol in assessment and management of cardiovascular disease risk. Clinical Pharmacology and Therapeutics, 96(1), 20-22. https://doi.org/10.1038/clpt.2014.69